{"chunk_type":"transcript_chunk","text":"**Step 1: Access**\n- **2 Large Bore IV Catheters (18G or larger).** ì°”ë”ì°”ë” ë“¤ì–´ê°€ëŠ” ì–‡ì€ ë¼ì¸ì€ ì•ˆ ë©ë‹ˆë‹¤. Flowê°€ ìƒëª…ì…ë‹ˆë‹¤.\n**Step 2: Medication Cocktail (3ê°€ì§€ ë™ì‹œì—!)**\n1. **Fluids:** Volume resuscitation.\n2. **IV Octreotide:**\n    - Splanchnic vasoconstrictionì„ ìœ ë°œí•˜ì—¬ Portal systemìœ¼ë¡œ ë“¤ì–´ê°€ëŠ” í˜ˆë¥˜ëŸ‰ì„ ì¤„ì…ë‹ˆë‹¤. (\"ìˆ˜ë„ê¼­ì§€ë¥¼ ì ê·¸ëŠ” ì—­í• \")\n3. **â˜… Antibiotics (IV Ceftriaxone for 7 days):**\n    - **ì´ê±¸ ìŠìœ¼ë©´ ê°ì !** Cirrhosis í™˜ìê°€ GI Bleedingì´ ìƒê¸°ë©´ ì¥ë‚´ ì„¸ê·  ì´ë™(Translocation)ìœ¼ë¡œ **SBP (Spontaneous Bacterial Peritonitis)** ìœ„í—˜ì´ ê¸‰ì¦í•©ë‹ˆë‹¤.\n    - í•­ìƒì œ íˆ¬ì—¬ëŠ” **Mortality**ë¥¼ ë‚®ì¶”ëŠ” í•„ìˆ˜ ì¡°ì¹˜ì…ë‹ˆë‹¤.\n**Step 3: Airway Protection (Critical Decision)**\n- í™˜ìê°€ ì˜ì‹ì´ ë–¨ì–´ì§€ê±°ë‚˜(Depressed mental status), í”¼ë¥¼ ê³„ì† í† í•œë‹¤ë©´?\n- **Intubate FIRST!** ğŸŒ¬ï¸\n- ë‚´ì‹œê²½(EGD) ë„£ê¸° ì „ì— ê¸°ë„ë¥¼ í™•ë³´í•´ì•¼ í•©ë‹ˆë‹¤. ì•ˆ ê·¸ëŸ¬ë©´ Aspiration Pneumoniaë¡œ í™˜ìë¥¼ ìƒìŠµë‹ˆë‹¤.\n**Step 4: The Procedure (Definitive Tx)**\n- **Urgent Endoscopy (EGD)**\n- **Treatment:** **Band Ligation** (ì •ë§¥ë¥˜ë¥¼ ê³ ë¬´ì¤„ë¡œ ë¬¶ì–´ ê´´ì‚¬ì‹œí‚´).\n**Step 5: Troubleshooting (í”¼ê°€ ì•ˆ ë©ˆì¶”ë©´?)**\n- ë‚´ì‹œê²½ìœ¼ë¡œë„ ì§€í˜ˆ ì‹¤íŒ¨ ì‹œ: **Balloon Tamponade** (Sengstaken-Blakemore tube).\n    - ì‹ë„/ìœ„ ì•ˆì—ì„œ í’ì„ ì„ ë¶ˆì–´ ë¬¼ë¦¬ì ìœ¼ë¡œ í˜ˆê´€ì„ ì••ë°•í•©ë‹ˆë‹¤.\n    - **ì£¼ì˜:** ì´ê±´ **Temporary Bridge** (ìµœëŒ€ 24ì‹œê°„)ì…ë‹ˆë‹¤. ì˜êµ¬ì ì¸ ì¹˜ë£Œë²•ì´ ì•„ë‹™ë‹ˆë‹¤.\n- **Re-bleeding (ì¬ì¶œí˜ˆ) ì‹œ:**\n    - Repeat Endoscopy -> ë‹¤ì‹œ ì‹œë„.\n    - ê·¸ë˜ë„ ì‹¤íŒ¨í•˜ë©´? â¡ï¸ **TIPS (Transjugular Intrahepatic Portosystemic Shunt)**\n        - ê°„ì„ ìš°íšŒí•˜ì—¬ Portal pressureë¥¼ ë‚®ì¶”ëŠ” ì‹œìˆ  (Interventional Radiology).\n**Step 6: Secondary Prophylaxis (í‡´ì› í›„ ê´€ë¦¬)**\n- ì•ˆì •ì´ ëœ í›„ì—ëŠ” ì¬ë°œ ë°©ì§€ë¥¼ ìœ„í•´ **Non-selective Beta-blocker (Nadolol, Propranolol)**ë¥¼ ì‹œì‘í•©ë‹ˆë‹¤.\n- 1-2ì£¼ ë’¤ì— **Repeat Band Ligation**ì„ ìŠ¤ì¼€ì¤„ ì¡ìŠµë‹ˆë‹¤.\n---\n### **3. Hematochezia & Occult Bleeding (Item 17.2)**\n**Clinical Vignette:** 55ì„¸ í™˜ì, **Bright Red Blood Per Rectum (BRBPR)** í˜¸ì†Œ.\n### **âš–ï¸ The \"Stability\" Fork**\nì—¬ê¸°ì„œ ê°€ì¥ ì¤‘ìš”í•œ ê±´ í™˜ìê°€ **Stable**í•œì§€ **Unstable**í•œì§€ì…ë‹ˆë‹¤.\n1. **Stable Patient:**\n    - **Next Best Step:** **Colonoscopy**.\n    - ì²œì²œíˆ ì›ì¸(Diverticulosis, Cancer, Angiodysplasia ë“±)ì„ ì°¾ìœ¼ë©´ ë©ë‹ˆë‹¤.\n    - Colono ìŒì„± â†’ EGD. EGD ìŒì„± â†’ OCCULT\n        - look for small intestine: capsule ë‚´ì‹œê²½\n        - Angyiodysplasia\n            - Heydeâ€™s sydrome: Arotic stenosis\n            - Renal disease\n2. **Unstable Patient (Hypotensive, Tachycardic):**\n    - **Trap!** ğŸš¨ í˜ˆë³€(Hematochezia)ì´ë¼ê³  ë¬´ì¡°ê±´ Lower GI Bleedê°€ ì•„ë‹™ë‹ˆë‹¤.\n    - **Massive Upper GI Bleed**ê°€ ì¥ì„ ë„ˆë¬´ ë¹¨ë¦¬ í†µê³¼í•˜ë©´(Rapid transit), í”¼ê°€ ê²€ê²Œ ë³€í•  ì‹œê°„(Melena) ì—†ì´ ë¹¨ê°„ìƒ‰ ê·¸ëŒ€ë¡œ ë‚˜ì˜µë‹ˆë‹¤.\n    - **Management:**\n        1. **Resuscitate** (ìˆ˜ì•¡, í˜ˆì•¡).\n        2. **EGD (Upper Endoscopy) FIRST!** â¡ï¸ ìœ„ì¥ê´€ ì¶œí˜ˆ(Upper source)ì„ ë¨¼ì € ë°°ì œí•´ì•¼ í•©ë‹ˆë‹¤.\n        3. EGDê°€ ê¹¨ë—í•œë°(Negative) ê³„ì† í”¼ê°€ ë‚œë‹¤ë©´?\n        4. **Angiography (Interventional Radiology):** ì¶œí˜ˆ í˜ˆê´€ì„ ì°¾ì•„ ìƒ‰ì „ìˆ (Embolization) ì‹œí–‰. (ëŒ€ì¥ë‚´ì‹œê²½ì€ í”¼, ë˜¥ë°”ë‹¤ ì†ì—ì„œ ì‹œì•¼ í™•ë³´ê°€ ì•ˆ ë¼ì„œ Unstable í•  ë•Œ ëª» ì”ë‹ˆë‹¤.)\nnote:\n- ì–´ë¥¸ ê°€ì¥ í”í•œ lower GI bleeding: diverticulosis â†’ erosion â†’ massive painless bleeding\n- ì†Œì•„: Meckelâ€™s diverticulum: massive painless bleeding: í•µ scan","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-404","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"---\n### **4. Hemobilia (Item 17.3)**\në§¤ìš° ë“œë¬¼ì§€ë§Œ, USMLEê°€ ì¢‹ì•„í•˜ëŠ” \"ì¡±ë³´\" í† í”½ì…ë‹ˆë‹¤.\n- **Scenario:** í™˜ìê°€ ìµœê·¼ **Liver Biopsy**ë¥¼ í–ˆê±°ë‚˜ ë³µë¶€ ì™¸ìƒ(Trauma)ì´ ìˆì—ˆìŒ.\n- **Symptoms (Quincke's Triad):**\n    1. **RUQ Pain** (ìš°ìƒë³µë¶€ í†µì¦)\n    2. **Jaundice** (í™©ë‹¬ - ë‹´ë„ê°€ ë§‰í˜€ì„œ)\n    3. **GI Bleeding** (í˜ˆì•¡ì´ ë‹´ë„ë¡œ í˜ëŸ¬ ë“¤ì–´ê°)\n- **Pathophysiology:** ê°„ë‚´ í˜ˆê´€ê³¼ ë‹´ë„ ì‚¬ì´ì— ëˆ„ê³µ(Fistula)ì´ ìƒê²¨ ë‹´ë„(Biliary tree)ë¡œ í”¼ê°€ íë¥´ëŠ” ê²ƒ.\n- **Dx & Tx:**\n    - Usually self limiting\n    - **Angiography with Embolization**. (í”¼ íë¦„ì„ ë§‰ì•„ì•¼ í•¨).\n---\n## ğŸ”¥ **Rapid Fire Recap (High Yield Summary)**\n| **Clinical Vignette (ìƒí™©)** | **Diagnosis / Context** | **Key Action / Next Best Step** |\n| --- | --- | --- |\n| **Cirrhosis + Hematemesis** | **Variceal Hemorrhage** | **2 Large Bore IVs + Octreotide + Ceftriaxone** (í•­ìƒì œ í•„ìˆ˜!) |\n| **Vomiting blood + Altered Mental Status** | **Airway Risk** | **Intubate** before Endoscopy |\n| **Active Bleeding + Platelets 40k** | **Thrombocytopenia** | **Transfuse Platelets** (Threshold < 50k for active bleed) |\n| **Hb drops after 2L Saline** | **Dilution (Not re-bleed)** | **Observation** (Don't panic) |\n| **Unstable + Bright Red Blood per Rectum** | **Massive UGIB (Rapid transit)** | **EGD (Upper Endoscopy)** first to rule out Upper source |\n| **Recent Liver Biopsy + RUQ Pain + Jaundice** | **Hemobilia** | **Angiography** (Embolization) |\n| **Variceal Bleeding Refractory to Banding** | **Failed Endoscopy** | **TIPS** (Definitive) or Balloon Tamponade (Bridge) |\n---\n**ğŸ‘¨â€âš•ï¸ Tutor's One-Liner:**\n\"ì„ ìƒë‹˜, GI Bleed í™˜ìëŠ” **'í”¼ë¥¼ ì–´ë””ê¹Œì§€ í˜ë ¤ë„ ë˜ë‚˜(Thresholds)'**ì™€ **'ì•ˆì •ì ì¸ê°€(Stability)'** ë‘ ê°€ì§€ë§Œ ê¸°ì–µí•˜ë©´ ë°˜ì€ ë¨¹ê³  ë“¤ì–´ê°‘ë‹ˆë‹¤. íŠ¹íˆ **Unstableí•œ í˜ˆë³€ í™˜ìì—ì„œ EGD ë¨¼ì €** ì°Œë¥´ëŠ” ê²ƒ, ì´ê±° ë‚šì‹œ ë¬¸ì œë¡œ ì§„ì§œ ë§ì´ ë‚˜ì˜¤ë‹ˆê¹Œ ê¼­ ì±™ê²¨ê°€ì„¸ìš”! í™”ì´íŒ…!\" ğŸ’ª","subject":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","page_title":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","episode":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","section_path":["LM_GIT3 2f946f2986ee805c848ac73de9876eba"],"source_doc_id":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","source_page":null,"source_anchor":"LM_GIT3 2f946f2986ee805c848ac73de9876eba-424","focus_area":"LM_GIT3 2f946f2986ee805c848ac73de9876eba","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"# ACS\n```mermaid\ngraph LR\n    %% 1. STEMI ì„¹ì…˜\n    subgraph STEMI [\"1. STEMI (Acute, 100% Blocked)\"]\n        direction LR\n        S1[í‰í†µ ë°œìƒ <br> EKG STìƒìŠ¹ / Trop++]\n        S1 --> S3[\"ğŸ“˜ ì´ˆê¸°ì¹˜ë£Œ: MONASH + BB <br> (Heparin-O, Nitrate-O, ACEi-X)\"]\n        S3 --> S4[\"ğŸ“˜ ì¬ê´€ë¥˜: Primary PCI\"]\n        S4 --> S5[\"ğŸ“˜ í•©ë³‘ì¦ ê´€ë¦¬\"]\n        S5 --> S6[\"ğŸ“˜ í‰ìƒì¹˜ë£Œ: BASS M <br> (ACEi/ARB, Spirono, SGLT2-O)\"]\n\n    end\n%% ë””ìì¸ ì„¸íŒ…\n    style S3 fill:#f0f7ff,stroke:#007bff\n        style S4 fill:#f0f7ff,stroke:#007bff\n                style S5 fill:#f0f7ff,stroke:#007bff\nstyle S6 fill:#f0f7ff,stroke:#007bff\n```\n```mermaid\ngraph LR\n    subgraph NSTEMI [\"2. NSTEMI/UA (Acute, Partial)\"]\n        direction LR\n        N2[\"í‰í†µë°œìƒ <br> EKG STD or ì •ìƒ or Trop+\"] --> N3\n        N3[\"ğŸ“˜ ì´ˆê¸°ì¹˜ë£Œ: MONASH + BB <br> (Heparin-O, Nitrate-O, ACEi-X)\"] --> N4{\"ğŸ“˜ ìœ„í—˜ë„ í‰ê°€\"}\n%% 1. ìœ„í—˜ë„ ê·¸ë£¹: íˆ¬ëª…ì„ (~~~) ì œê±°í•˜ê³  ìˆœìˆ˜í•˜ê²Œ ë¬¶ìŒ\n        subgraph Risk_Group [\"Risk Categories\"]\n            direction TB\n            N97[\"High/Refractory<br>í˜ˆì—­í•™ì  ë¶ˆì•ˆ\"]\n            N98[\"Intermediate\"]\n            N99[\"Low Risk<br>ì‹¬ì¥ì¸ì§€ ì•„ë‹Œì§€ ì• ë§¤í•˜ë‹¤\"]\n        end\n%% 2. ì¹˜ë£Œë²• ê·¸ë£¹: ì—¬ê¸°ë„ íˆ¬ëª…ì„  ì œê±°\n        subgraph Action_Group [\"Management Strategy\"]\n            direction TB\n            N5[\"2h ë‚´ PCI\"]\n            N6[\"24h ë‚´ PCI\"]\n            N7[\"Non-invasive Evalulation<br>Stress testâ­ or CT\"]\n        end\n%% 3. ì—°ê²°: ë¶€ëª¨(N4)ì—ì„œ ìì‹ë“¤ë¡œ ê°ê° ì—°ê²°\n        N4 --> N97\n        N4 --> N98\n        N4 --> N99\n%% 4. 1:1 ëŒ€ì‘ ì—°ê²° (ìˆ˜í‰ ìœ ì§€)\n        N97 --> N5\n        N98 --> N6\n        N99 --> N7\n%% ê²°ê³¼ ì„¹ì…˜\n        subgraph Evaluation [\"Result\"]\n            direction TB\n            N7 -- \"í˜‘ì°© ì—†ìŒ\" --> N9[\"í‡´ì›\"]\n            N7 -- \"í˜‘ì°© ìˆìŒ\" --> N8[\"CAG\"]\n        end\nN5 & N6 & N8 --> N100[\"ğŸ“˜ í‰ìƒì¹˜ë£Œ: BASS M <br> (ACEi/ARB, Spirono, SGLT2-O)\"]\n%% ìŠ¤íƒ€ì¼ë§: ë°•ìŠ¤ í…Œë‘ë¦¬ íˆ¬ëª…í™” (í•„ìˆ˜ ì•„ë‹˜)\n        style Risk_Group fill:none,stroke:none\n        style Action_Group fill:none,stroke:none\n        style N3 fill:#f0f7ff,stroke:#007bff\n        style N4 fill:#f0f7ff,stroke:#007bff\n       style N100 fill:#f0f7ff,stroke:#007bff\n              style N5 fill:#f0f7ff,stroke:#007bff\n                     style N6 fill:#f0f7ff,stroke:#007bff\n                            style N7 fill:#f0f7ff,stroke:#007bff\n    end\n```\n```mermaid\ngraph LR\nsubgraph Stable_Angina [\"3. Stable Angina Workflow\"]\ndirection LR\nN2[\"Exertional í‰í†µ\"] --> N4\nsubgraph P [\" \"]\nN4[\"ğŸ“˜ í™•ë¥ í‰ê°€ (PTP)\"]\nN7[\"ğŸŸ¢ Low Risk (<15%)<br>20ëŒ€ ì½•ì½•ì•„í”” <br> ì¢…ê²°\"]\n   N_Desc[\"<div style='text-align:left; font-size:12px; line-height:1.4;'><b>1. Typicality</b><br>â€¢ Location, Provocation, Palliation<br><br><b>2. Risk Factors</b><br>â€¢ HTN, DM, Dyslipidemia, Smoking<br><br><b>3. Equivalents</b><br>â€¢ CKD, PAD, Established CAD<br><br><b>4. DDx</b><br>â€¢ GERD, PE, Aortic Dissection</div>\"]\nend","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-1","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"%% 2. [ìœ„í—˜ë„ ê¸°ë‘¥] Low -> High ìˆœì„œ (íˆ¬ëª…ì„  ëŒ€ì‹  invisible link ì‚¬ìš©)\nsubgraph Risk_Block [\"Step 2: Risk Stratification\"]\ndirection TB\nN6[\"ğŸŸ  Intermediate (15-85%)<br> 40ëŒ€ ë‚¨ì\"]\nN5[\"ğŸ”´ High Risk (>85%)<br> ë‹¹ë‡¨ 70ëŒ€ í• ì•„ë²„ì§€\"]\n%% [í•µì‹¬] ì‹¤ì œ í™”ì‚´í‘œë¡œ ì—°ê²°í•˜ë˜ ë‚˜ì¤‘ì— ì•ˆ ë³´ì´ê²Œ ì²˜ë¦¬ (ìˆœì„œ ê°•ì œ)\nend\n%% 3. [ì¹˜ë£Œ ê¸°ë‘¥] ìœ„ ìˆœì„œì— ëŒ€ì‘\nsubgraph Action_Block [\"Step 3: Workup Strategy\"]\ndirection TB\nN51[\"Non-invasive Eval<br>(Stress testâ­ / CCTA) <br> i. ìš´ë™+EKG <br> ii. ìš´ë™+ì˜ìƒ <br> iii. ì•½ë¬¼+ì˜ìƒ\"]\nN88[\"Direct CAG (Invasive) <br> ë°”ë¡œ CAGí•¨!!\"]\n%% ì—¬ê¸°ë„ ìˆœì„œ ê°•ì œ\nend\n%% 4. ê° ë‹¨ê³„ ì—°ê²° (ê°€ë¡œ)\nN4 --> N6\nN4 --> N5\nN6 --> N51\nN5 --> N88\n%% 5. ê²°ê³¼ (Evaluation)","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-21","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core","diagnosis"]}
{"chunk_type":"transcript_chunk","text":"subgraph Result_Block [\"Final Decision\"]\ndirection TB\nN77[\"CAG\"]\nN78[\"OMT / Revasc <br> BB Aspirin Statin Â± ACEIARB Â± spironolactone\"]\nend\nN51 -- \"í˜‘ì°©ì´ ì‹¬í•¨ <br> ë°”ë¡œ STD ë‚˜íƒ€ë‚¨, ì €í˜ˆì••\" --> N77\nN51 -- \"Negative\" --> N78\nN88 --> N77\nN77 --> N78\n%% ë°•ìŠ¤ í…Œë‘ë¦¬ ì œê±°\nstyle Risk_Block fill:none,stroke:none\nstyle Action_Block fill:none,stroke:none\nstyle Result_Block fill:none,stroke:none\n%% ë…¸ë“œ ë””ìì¸\nstyle N4 fill:#e3f2fd,stroke:#007bff,stroke-width:2px\nstyle N7 fill:#e8f5e9,stroke:#388e3c\nstyle N5 fill:#ffebee,stroke:#d32f2f\nstyle N6 fill:#fff3e0,stroke:#f57c00\nstyle N51 fill:#fff3e0,stroke:#f57c00\nstyle N88 fill:#ffebee,stroke:#d32f2f","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-41","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"end\n```","subject":"ACS 2f546f2986ee80e28108e122ed92ca06","page_title":"ACS 2f546f2986ee80e28108e122ed92ca06","episode":"ACS 2f546f2986ee80e28108e122ed92ca06","section_path":["ACS 2f546f2986ee80e28108e122ed92ca06"],"source_doc_id":"ACS 2f546f2986ee80e28108e122ed92ca06","source_page":null,"source_anchor":"ACS 2f546f2986ee80e28108e122ed92ca06-61","focus_area":"ACS 2f546f2986ee80e28108e122ed92ca06","tags":["usmle-step2","core"]}
{"chunk_type":"transcript_chunk","text":"# LM_Blood 1\n---\n# ğŸ©¸ **USMLE Step 2 CK: Hematology - Red Blood Cells & Anemia Algorithms**\n### **(HemOnc Map Sections 1.0 - 1.2)**\nì•ˆë…•í•˜ì„¸ìš”! ì˜¤ëŠ˜ë„ Deep Diveì˜ ë‚´ìš©ì„ ë°”íƒ•ìœ¼ë¡œ **USMLE Step 2 CK**ë¥¼ ìœ„í•œ ì¡±ì§‘ê²Œ ê°•ì˜ë¥¼ ì‹œì‘í•´ ë´…ì‹œë‹¤. ğŸ©º ì˜¤ëŠ˜ì€ **Anemia(ë¹ˆí˜ˆ)** íŒŒíŠ¸ì…ë‹ˆë‹¤. ë‹¨ìˆœíˆ 'Hbê°€ ë‚®ë‹¤'ê°€ ì•„ë‹ˆë¼, **\"Why is the assembly line broken?\"** (ì™œ ê³µì¥ì´ ë©ˆì·„ë‚˜?)ë¥¼ íŒŒì•…í•˜ëŠ” ê²ƒì´ í•µì‹¬ì…ë‹ˆë‹¤.\nêµ°ì˜ê´€ë‹˜ê»˜ì„œ ì¢‹ì•„í•˜ì‹œëŠ” **Top-down Classification**ë¶€í„° ì¡ê³  ë“¤ì–´ê°‘ë‹ˆë‹¤! ğŸŒ³\n## **ğŸŒ³ The Big Picture: Anemia Algorithm Tree**\nPlaintext\n`ANEMIA (Low Hb)\nâ”‚\nâ”œâ”€â”€ 1. Production Failure (Factory Problem) [Reticulocyte Count < 2%]\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Microcytic (MCV < 80)\nâ”‚   â”‚   â”œâ”€â”€ Iron Deficiency Anemia (IDA) - Raw material shortage\nâ”‚   â”‚   â”œâ”€â”€ Thalassemia - Globin defect (Genetic blueprint error)\nâ”‚   â”‚   â”œâ”€â”€ Anemia of Chronic Disease (ACD) - Iron lockdown (Hepcidin)\nâ”‚   â”‚   â””â”€â”€ Sideroblastic Anemia - Protoporphyrin defect\nâ”‚   â”‚\nâ”‚   â”œâ”€â”€ Normocytic (MCV 80-100)\nâ”‚   â”‚   â”œâ”€â”€ Anemia of Chronic Disease (Early)\nâ”‚   â”‚   â”œâ”€â”€ Aplastic Anemia (Factory destruction)\nâ”‚   â”‚   â””â”€â”€ CKD (No EPO signal)\nâ”‚   â”‚\nâ”‚   â””â”€â”€ Macrocytic (MCV > 100)\nâ”‚       â”œâ”€â”€ Megaloblastic (DNA Synthesis Issue)\nâ”‚       â”‚   â”œâ”€â”€ B12 Deficiency\nâ”‚       â”‚   â””â”€â”€ Folate Deficiency\nâ”‚       â””â”€â”€ Non-Megaloblastic\nâ”‚           â”œâ”€â”€ Alcohol / Liver Disease\nâ”‚           â”œâ”€â”€ Hypothyroidism\nâ”‚           â””â”€â”€ Drugs (Hydroxyurea, MTX)\nâ”‚\nâ””â”€â”€ 2. Destruction or Loss (Product Loss) [Reticulocyte Count > 2%]\n    â”‚\n    â”œâ”€â”€ Blood Loss (Obvious leak)\n    â”‚\n    â””â”€â”€ Hemolysis (Destruction)\n        â”œâ”€â”€ Intrinsic (Born with defect)\n        â”‚   â”œâ”€â”€ Membrane: Hereditary Spherocytosis\n        â”‚   â”œâ”€â”€ Enzyme: G6PD Deficiency\n        â”‚   â””â”€â”€ Hemoglobin: Sickle Cell\n        â”‚\n        â””â”€â”€ Extrinsic (Environment is hostile)\n            â”œâ”€â”€ Immune: AIHA (Autoimmune)\n            â”œâ”€â”€ Non-Immune: MAHA (TTP/HUS, DIC), Mechanical Heart Valve`\n---\n## **1.0 RBC General: Factory vs. Destruction** ğŸ­ğŸ’¥\nê°€ì¥ ë¨¼ì € í•´ì•¼ í•  ì§ˆë¬¸: **\"ê³µì¥ì´ ê³ ì¥ ë‚¬ëŠ”ê°€(Production Failure), ì•„ë‹ˆë©´ ë§Œë“¤ì–´ì§„ ë¬¼ê±´ì´ ë¶€ì„œì§€ê³  ìˆëŠ”ê°€(Destruction/Loss)?\"**\n### **â˜… The Golden Rule: Reticulocyte Count**\nì´ê±¸ êµ¬ë¶„í•˜ëŠ” ìœ ì¼í•œ ì—´ì‡ ëŠ” **Reticulocyte Count**ì…ë‹ˆë‹¤.\n- **High Retic (>2% corrected):** ê³µì¥ì€ ë©€ì©¡í•¨! ì—´ì‹¬íˆ ë³´ìƒ ì¤‘ì„. â†’ **Hemolysis or Bleeding**.\n- **Low Retic (<2% corrected):** ê³µì¥ì´ ì…§ë‹¤ìš´ ë¨. â†’ **Production Failure** (ì¬ë£Œ ë¶€ì¡± or ê³¨ìˆ˜ ë¬¸ì œ).\n### **Hemolysis: Intrinsic vs. Extrinsic**\n- **Intrinsic (Internal Hardware Problem):** ì„¸í¬ ìì²´ê°€ ë¶ˆëŸ‰í’ˆìœ¼ë¡œ íƒœì–´ë‚œ ê²½ìš°.\n    - **Membrane:** Hereditary Spherocytosis (ë™ê¸€ë™ê¸€í•´ì„œ ì˜ í„°ì§)\n    - **Enzyme:** G6PD Deficiency (ì‚°í™” ìŠ¤íŠ¸ë ˆìŠ¤ì— ì•½í•¨)\n    - **Hemoglobin:** Sickle Cell, Thalassemia\n- **Extrinsic (External Environment Problem):** ì„¸í¬ëŠ” ì •ìƒì¸ë° ë°–ì—ì„œ ëˆ„ê°€ ë•Œë¦¬ëŠ” ê²½ìš°.\n    - **Immune:** Autoimmune Hemolytic Anemia (AIHA) - ë‚´ ëª¸ì´ ì•„êµ° ì‚¬ê²©.\n    - **Non-Immune:** Mechanical Heart Valve(ë¬¼ë¦¬ì  ì¶©ê²©), Microangiopathic(í˜ˆê´€ì´ ì¢ì•„ì„œ ì°¢ì–´ì§ - TTP, HUS).","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-1","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","tree"]}
{"chunk_type":"transcript_chunk","text":"---\n## **1.1 Microcytic Anemia (MCV < 80)** ğŸ¤\n: \"ì‘ì€ ì„¸í¬ë“¤\" = í—¤ëª¨ê¸€ë¡œë¹ˆì„ ì±„ìš¸ ì¬ë£Œê°€ ë¶€ì¡±í•˜ê±°ë‚˜ ë¶ˆëŸ‰í’ˆì¸ ìƒíƒœ.\n### **ğŸ§ª Critical Vignette: The CKD Trap**\n- **Case:** íˆ¬ì„ ì¤‘ì¸ CKD í™˜ì. EPO(Erythropoietin)ë¥¼ íˆ¬ì—¬í–ˆëŠ”ë° ê°‘ìê¸° Hbê°€ ì •ì²´ë˜ê³  MCVê°€ ëš ë–¨ì–´ì§. ì™œ ê·¸ëŸ´ê¹Œ?\n- **Mechanism:** EPOë¥¼ ì£¼ë©´ ê³¨ìˆ˜ ê³µì¥ì´ ë¯¸ì¹œ ë“¯ì´ ëŒì•„ê°‘ë‹ˆë‹¤(Rev up!). ê·¸ëŸ¬ë©´ ì €ì¥í•´ ë‘” ì² ë¶„ì„ ìˆœì‹ê°„ì— ë‹¤ ì¨ë²„ë¦½ë‹ˆë‹¤. â†’ **Functional Iron Deficiency** ë°œìƒ.\n- **Treatment:** **IV Iron** (Not Oral!).\n    - Why? CKD í™˜ìëŠ” ì—¼ì¦ ìƒíƒœ(Inflammation)ë¼ **Hepcidin** ìˆ˜ì¹˜ê°€ ë†’ìŠµë‹ˆë‹¤. Hepcidinì€ ì¥(Gut)ì—ì„œ ì² ë¶„ì´ í¡ìˆ˜ë˜ëŠ” ë¬¸ì„ ì ê°€ë²„ë¦¬ê¸° ë•Œë¬¸ì— Oral Ironì€ í¡ìˆ˜ê°€ ì•ˆ ë©ë‹ˆë‹¤.\n### **ğŸ§¬ Thalassemia Screening Protocol**\n- **Step 1:** CBC í™•ì¸ (MCVê°€ ë§¤ìš° ë‚®ìŒ).\n- **Step 2 (Next Best Step):** **Hb Electrophoresis**.\n- **Don't:** ìœ ì „ì ê²€ì‚¬(Genetic testing)ë¶€í„° í•˜ì§€ ë§ˆì„¸ìš”. ë„ˆë¬´ ë¹„ì‹¸ê³  ë¶ˆí•„ìš”í•©ë‹ˆë‹¤.\n### **ğŸ§  Mentzer Index (Tying breaker)**\nMCVê°€ ë‚®ì€ë°, ì´ê²Œ ì² ë¶„ ê²°í•(IDA)ì¸ì§€ Thalassemiaì¸ì§€ í—·ê°ˆë¦´ ë•Œ ì”ë‹ˆë‹¤.\n- **Formula:** MCV / RBC count\n- **< 13 (Thalassemia):** ì„¸í¬ê°€ ì—„ì²­ ì‘ê³ (MCV â†“), ê°œìˆ˜ëŠ” ë§ìŒ(RBC â†‘). ë¶ˆëŸ‰í’ˆì„ ë§ì´ ì°ì–´ë‚´ëŠ” ìƒíƒœ.\n- **> 13 (Iron Deficiency):** ì¬ë£Œê°€ ì—†ì–´ì„œ ê³µì¥ì´ ë©ˆì¶¤. RBC ê°œìˆ˜ ìì²´ê°€ ì¤„ì–´ë“¦.\n### Anemia â†’ Reactive thrombocytosis\n- RBCë‘ Platelet (megakaryocyte)ëŠ” ê°™ì€ lineage\\\n- Anemiaì—ì„œ RBCë§ì´ ë§Œë“œëŠ” ìê·¹ì´ ë“¤ì–´ì˜¤ë©´ plateletì´ ì¦ê°€í•¨.\n- Anemiaì—ì„œ platelet ëŠ˜ì–´ë„ ë†€ë¼ì§€ë§ˆì„¸ìš”.\n| **í•­ëª©** | **IDA (ì² ê²°í•ì„±)** | **ACD (ë§Œì„±ì§ˆí™˜)** | **Thalassemia (ì§€ì¤‘í•´)** | **ë¹„ê³  (Mental Model)** |\n| --- | --- | --- | --- | --- |\n| **MCV** | **Down** ğŸ“‰ | **Normal or Down** ğŸ“‰ | **Way Down** ğŸ“‰ğŸ“‰ | ACDëŠ” Normocyticì¸ ê²½ìš°ë„ ë§ìŒ! |\n| **RDW** | **Up** ğŸ“ˆ â˜… | **Normal** â†”ï¸ | **Normal** â†”ï¸ | IDAëŠ” í¬ê¸°ê°€ ì œê°ê°, ThalassemiaëŠ” ë‹¤ ê°™ì´ ì‘ìŒ. |\n| **RBC Count** | **Down** ğŸ“‰ | **Down** ğŸ“‰ | **Normal or Up** ğŸ“ˆ â˜… | ThalassemiaëŠ” ê°œìˆ˜ëŠ” ë§ì§€ë§Œ ì§ˆì´ ë–¨ì–´ì§. |\n| **P/S (ë§ì´ˆë„ë§)** | **Microcytic/Hypochromic** |  | **Target cell**, Basophilic stippling | IDAëŠ” ë»¥ ëš«ë¦° ê³ ë¦¬ ëª¨ì–‘ ì„¸í¬.\nì í˜ˆêµ¬ì˜ 'í‘œë©´ì (Cell Membrane)'ì— ë¹„í•´ 'ë‚´ìš©ë¬¼(Hemoglobin)'ì´ ë„ˆë¬´ ì ìŒ.\nThalassemiaì²˜ëŸ¼ í—¤ëª¨ê¸€ë¡œë¹ˆ í•©ì„±ì´ ì•ˆ ë˜ë©´, ì•ˆìª½ì´ í—ë í•´ì§€ë©´ì„œ ì„¸í¬ê°€ ì­ˆê¸€ |\n| **Serum Iron** | **Down** ğŸ“‰ | **Down** ğŸ“‰ â˜… | **Normal or Up** ğŸ“ˆ | ACDëŠ” í”¼ ì†ì— ì² ì´ ì—†ì–´ì„œ IDAì™€ í—·ê°ˆë¦¼! |\n| **Ferritin** | **Down** ğŸ“‰ â˜… | **Normal or Up** ğŸ“ˆ â˜… | **Normal or Up** ğŸ“ˆ | **ê°€ì¥ ì¤‘ìš”í•œ ì°¨ì´ì !** ACDëŠ” ì €ì¥ê³ ì— ì² ì´ ê°€ë“í•¨! |\n| **TIBC** | **Up** ğŸ“ˆ | **Down** ğŸ“‰ â˜… | **Normal** â†”ï¸ | **TIBC= Truck=negative acute phase reactant**\nì² ì´ ì—†ìœ¼ë‹ˆ íŠ¸ëŸ­ì„ í•œëŒ€ë¼ë„ ëŠ˜ë¦¼.\nì—¼ì¦ì—ì„œëŠ” ì„¸ê· í•œí…Œ ì²  ê°–ë‹¤ì£¼ëŠ” íŠ¸ëŸ­ ê¼´ë² ê¸° ì‹«ì–´ì„œ ê°„ì—ì„œ ì•ˆë§Œë“¤ì–´ì¤Œ. |\n| **Target Cell** | ë“œë¬¾ | ì—†ìŒ | **ìì£¼ ê´€ì°°ë¨** ğŸ¯ | Thalassemiaì˜ ì‹œê·¸ë‹ˆì²˜! |\n### **ğŸ”’ Anemia of Chronic Disease (ACD)**\n- **Core Concept:** **Hepcidin**ì´ í•µì‹¬ ë¹ŒëŸ°.\n- **Mechanism:** ìš°ë¦¬ ëª¸ì´ ê°ì—¼/ì—¼ì¦ ìƒíƒœì¼ ë•Œ, ì„¸ê· ì´ ì² ë¶„ì„ ëª» ì“°ê²Œ í•˜ë ¤ê³  ì² ë¶„ì„ **Macrophage ì•ˆì— ê°€ë‘¬ë²„ë¦½ë‹ˆë‹¤(Lockdown).**\n- **Labs:**\n    - Serum Iron: â†“ (í˜ˆì•¡ ë‚´ ì² ë¶„ì€ ë‚®ìŒ)\n    - TIBC: â†“ (Transferrinì€ Negative acute phase reactantë¼ ì¤„ì–´ë“¦)\n        - ëª¸ì— ì—¼ì¦ì´ ìƒê¸°ë©´ ê°„ì—ì„œëŠ” â€˜truckâ€™ì„ ëœ ë§Œë“¦. ì„¸ê· ì— ì²  ì£¼ê¸° ì‹«ì–´ì„œ ê°„ì´ ê¼¬ì¥ë¶€ë¦¼.\n    - **Ferritin: â†‘ (â˜…Key Point)** (ì² ë¶„ì„ ì°½ê³  ì•ˆì— ê½‰ê½‰ ì±„ì›Œ ë†¨ìœ¼ë‹ˆ ì €ì¥ì² ì€ ë†’ìŒ!)\n---\n## **1.2 Macrocytic Anemia (MCV > 100)** ğŸˆ\n: \"í° ì„¸í¬ë“¤\" = DNA í•©ì„±ì´ ì•ˆ ë¼ì„œ ë¶„ì—´ì„ ëª» í•˜ê³  ëª¸ì§‘ë§Œ ë¶ˆë¦° ìƒíƒœ.","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-21","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","treatment","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"| Category | Causes |\n| --- | --- |\n| **Impaired RBC Maturation** | Vitamin B12/Folate deficiency, Medications (Hydroxyurea-DNA, Methotrexate-B9) |\n| **Increased Reticulocytes**\nReticulocyte í¬ê¸°ê°€ í¬ë‹¤ë³´ë‹ˆê¹Œ MCV í¬ê²Œ ë‚˜íƒ€ë‚¨. | **Hemolytic** anemia, Bone marrow recovery |\n| **Bone Marrow Disorders** | Myelodysplastic syndrome, Multiple myeloma, Sideroblastic anemia |\n| **Lipid Abnormalities**\nì„¸í¬ë§‰ì´ ë¬¸ì œì„. ì„¸í¬ë§‰ì´ ì•ˆì—†ì–´ì ¸ì„œ ì»¤ë³´ì„ | Liver disease, Hypothyroidism |\n### **ğŸ•µï¸â€â™‚ï¸ The Glossitis Vignette**\n- **Case:** ìœ„ì „ì ˆì œìˆ (Gastrectomy) ê³¼ê±°ë ¥. í˜€ê°€ ë°˜ë“¤ë°˜ë“¤í•¨(Glossitis). Labì—ì„œ LDH â†‘, Indirect Bilirubin â†‘.\n- **Trap:** LDHë†’ê³  indirect bilirubin ë†’ì•„ì„œ ìš©í˜ˆ(Hemolysis)ì¸ê°€? ê·¼ë° ì•„ë‹˜.\n    - **Truth:** **Intramedullary Hemolysis** (Ineffective Erythropoiesis). DNA í•©ì„±ì´ ì•ˆ ë˜ë‹ˆ ê³¨ìˆ˜ ì•ˆì—ì„œ ì„¸í¬ê°€ ë§Œë“¤ì–´ì§€ë‹¤ê°€ í„°ì ¸ ì£½ëŠ” ê²ƒ. ì‹¤ì œë¡œëŠ” **B12 Deficiency**ì…ë‹ˆë‹¤.\n### **B12 vs. Folate (The Showdown)**\në‘˜ ë‹¤ Megaloblastic Anemiaë¥¼ ì¼ìœ¼í‚¤ì§€ë§Œ, ê²°ì •ì  ì°¨ì´ê°€ ìˆìŠµë‹ˆë‹¤.\n| **Feature** | **Vitamin B12 (Cobalamin)** | **Folate (B9)** |\n| --- | --- | --- |\n| **Neuro Symptoms** | **Yes!** (Paresthesia, Ataxia) | No |\n| **Methylmalonic Acid (MMA)** | **High (â˜…Distinctive)** | Normal |\n| **Homocysteine** | High | High |\n| **Causes** | Pernicious Anemia, Gastrectomy, Vegans | Alcoholism, Diet (No veggies) |\n- **Pathophysiology (Neuro):** B12ëŠ” Methylmalonyl CoAë¥¼ ë³€í™˜í•˜ëŠ” ë° í•„ìš”í•œë°, ì—†ìœ¼ë©´ MMAê°€ ìŒ“ì—¬ì„œ ì‹ ê²½ì˜ Myelin sheathë¥¼ íŒŒê´´í•©ë‹ˆë‹¤ (Subacute Combined Degeneration).\n### **ğŸ’€ The \"Hypokalemia Death\" Trap (Clinical Pearl)**\n- **Scenario:** ì‹¬í•œ B12 ê²°í• í™˜ìì—ê²Œ B12 ì£¼ì‚¬ë¥¼ ì¤Œ. í™˜ìê°€ ë©°ì¹  ë’¤ ì‚¬ë§. ì™œ?\n- **Mechanism:** B12ê°€ ë“¤ì–´ì˜¤ë©´ ê³¨ìˆ˜ê°€ ë¯¸ì¹œ ë“¯ì´ ì í˜ˆêµ¬ë¥¼ ì°ì–´ë‚´ê¸° ì‹œì‘í•¨. ìƒˆë¡œìš´ ì„¸í¬ë“¤ì´ í˜ˆì•¡ ì†ì˜ **Potassium(K+)**ì„ ì„¸í¬ ì•ˆìœ¼ë¡œ ì«™ ë¹¨ì•„ë“¤ì„.\n- **Result:** Severe **Hypokalemia** â†’ Fatal Arrhythmia.\n- **Action:** B12 ì¹˜ë£Œ ì´ˆë°˜ì—ëŠ” ë°˜ë“œì‹œ **K+ ëª¨ë‹ˆí„°ë§ ë° ë³´ì¶©**ì„ í•´ì•¼ í•©ë‹ˆë‹¤!\n### **Other Macrocytic Causes (Non-Megaloblastic)**\nDNA ë¬¸ì œ ì—†ì´ ê·¸ëƒ¥ ì„¸í¬ë§‰ ë¬¸ì œ ë“±ìœ¼ë¡œ ì»¤ ë³´ì´ëŠ” ê²½ìš°ë“¤.\n- **Alcoholism / Liver Disease:** ì„¸í¬ë§‰ì— ì§€ì§ˆ(Lipid)ì´ ê»´ì„œ ì»¤ì§.\n- **Reticulocytosis:** ì•„ê¸° ì„¸í¬(Reticulocyte)ëŠ” ì›ë˜ í½ë‹ˆë‹¤. ìš©í˜ˆì´ ì‹¬í•˜ë©´ MCVê°€ ì»¤ ë³´ì¼ ìˆ˜ ìˆìŒ.\n- **Drugs:** Hydroxyurea (Sickle cell ì¹˜ë£Œì œ), Methotrexate.\n- **Hypothyroidism.**\n---","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-41","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","pathophysiology"]}
{"chunk_type":"recap_summary","text":"## **ğŸ”¥ Rapid Fire Recap (Summary)**\n1. **Vignette:** CKD on EPO, decreasing Hb.\n    - **Diagnosis:** Functional Iron Deficiency.\n    - **Action:** Give **IV Iron** (Not oral!).\n2. **Vignette:** Microcytic anemia, High Ferritin, Low TIBC.\n    - **Diagnosis:** Anemia of Chronic Disease (ACD).\n    - **Mechanism:** Hepcidin locking iron in macrophages.\n3. **Vignette:** Microcytic anemia, RBC count is actually high or normal. Mentzer Index < 13, Target cells.\n    - **Diagnosis:** **Thalassemia**.\n    - **Next Step:** Hb Electrophoresis.\n4. **Vignette:** Gastrectomy patient with neuropathy (tingling) & anemia.\n    - **Diagnosis:** B12 Deficiency.\n    - **Lab Clue:** High **Methylmalonic Acid (MMA)**.\n5. **Vignette:** Treating severe B12 deficiency, patient develops palpitations/weakness.\n    - **Complication:** **Hypokalemia**. (Cell turnover uses up K+).\n---\n**Confidence:** 1.0 (Based strictly on the provided audio content).\n**Caveat:** Mentzer IndexëŠ” ì£¼ë¡œ ì†Œì•„ê³¼(Pediatrics)ì—ì„œ ë§ì´ ë‚˜ì˜¤ì§€ë§Œ ì„±ì¸ ë‚´ê³¼(IM)ì—ì„œë„ ê°ë³„ í¬ì¸íŠ¸ë¡œ ìœ ìš©í•©ë‹ˆë‹¤. B12 ì¹˜ë£Œ ì‹œ HypokalemiaëŠ” ì‹¤ì „/ì‹œí—˜ ëª¨ë‘ì—ì„œ ë†“ì¹˜ë©´ ì•ˆ ë˜ëŠ” ì¹˜ëª…ì ì¸ í¬ì¸íŠ¸ì…ë‹ˆë‹¤!\n---\n# ğŸ©¸ **Intrinsic Hemolytic Anemias: The Deep Dive**\n<aside>\nğŸ’¡","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-55","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","recap","diagnosis","pathophysiology"]}
{"chunk_type":"transcript_chunk","text":"1. Enzyme defect?(G6PD) â†’ avoid trigger\n2. Membrane defect? (HS) â†’ remove the filter (splenectomy)\n3. Hemoglobin defect (SCD) â†’ fix o2 and acidosis state\n4. ì‰´ë“œê°€ ì—†ìŒ? (PNH) â†’ block complement pathway\n</aside>\n## **ğŸ“‹ Overview (TL;DR)**\nì˜¤ëŠ˜ì˜ Deep DiveëŠ” **USMLE Step 2 CK**ë¥¼ ì¤€ë¹„í•˜ëŠ” ìˆ˜í—˜ìƒì„ ìœ„í•´ **Intrinsic Hemolytic Anemias**ì˜ í•µì‹¬ ë³‘íƒœìƒë¦¬ì™€ ì„ìƒì  í•¨ì •(Clinical Pearls)ì„ ì™„ë²½í•˜ê²Œ í•´ë¶€í•©ë‹ˆë‹¤. ë‹¨ìˆœ ì•”ê¸°ê°€ ì•„ë‹ˆë¼ *Why*ë¥¼ ì´í•´í•´ì„œ ê¸°ì–µì— ë‚¨ë„ë¡ ì„¤ê³„ë˜ì—ˆìŠµë‹ˆë‹¤.\n- **Topic:** Intrinsic Hemolytic Anemias (Red Blood Cell Defects)\n- **Key Pathologies:**\n    1. **G6PD Deficiency**: The Shield Generator Failure ğŸ›¡ï¸\n    2. **PNH (Paroxysmal Nocturnal Hemoglobinuria)**: The Missing Anchor âš“ï¸\n    3. **Sickle Cell Disease**: The Shape-Shifter Crisis ğŸŒ™\n    4. **Hereditary Spherocytosis**: The Rigid Sphere ğŸˆ\n---\n## **ğŸŒ³ Top-Down Classification: Hemolytic Anemias**\nì˜í•™ì  Contextë¥¼ ì¡ê¸° ìœ„í•´ ê³„ì¸µ êµ¬ì¡°ë¥¼ ë¨¼ì € ë³´ì—¬ë“œë¦½ë‹ˆë‹¤. ìš°ë¦¬ê°€ ì˜¤ëŠ˜ ë‹¤ë£¨ëŠ” ë‚´ìš©ì€ **Intrinsic** íŒŒíŠ¸ì…ë‹ˆë‹¤.\nPlaintext\n`Anemia\nâ”œâ”€â”€ Microcytic (TAILS)\nâ”œâ”€â”€ Macrocytic\nâ””â”€â”€ Normocytic\n    â”œâ”€â”€ Non-Hemolytic (Low Reticulocyte Index)\n    â””â”€â”€ Hemolytic (High Reticulocyte Index)\n        â”œâ”€â”€ Extrinsic (Autoimmune, MAHA, Infections)\n        â””â”€â”€ Intrinsic (The RBC itself is the problem!) â˜… TODAY'S TOPIC\n            â”œâ”€â”€ Enzyme Defects\n            â”‚   â””â”€â”€ G6PD Deficiency (Oxidative Stress) ğŸ›¡ï¸\n            â”œâ”€â”€ Membrane Defects\n            â”‚   â”œâ”€â”€ PNH (Acquired, Stem cell defect) âš“ï¸\n            â”‚   â””â”€â”€ Hereditary Spherocytosis (Inherited, Cytoskeleton) ğŸˆ\n            â””â”€â”€ Hemoglobinopathies\n                â””â”€â”€ Sickle Cell Disease (HbS polymerization) ğŸŒ™`\n---\n## **1. G6PD Deficiency (1.3)**\n### **ğŸ›¡ï¸ Concept: The Broken Shield Generator**\n- **Analogy:** RBCëŠ” ì‚°ì†Œ(O2)ë¥¼ ìš´ë°˜í•˜ì§€ë§Œ, ì•„ì´ëŸ¬ë‹ˆí•˜ê²Œë„ ì‚°ì†ŒëŠ” **Free Radicals (Oxidative Stress)**ë¥¼ ë§Œë“­ë‹ˆë‹¤. ì´ë¥¼ ë§‰ì•„ì£¼ëŠ” **'Shield Generator'**ê°€ ë°”ë¡œ **Glutathione**ì…ë‹ˆë‹¤.\n- **Pathophysiology:**\n    - **G6PD enzyme**ì€ **NADPH**ë¥¼ ìƒì„± â†’ NADPHê°€ **Glutathione**ì„ ì¶©ì „(Recharge) â†’ Free Radical ì¤‘í™”.\n    - **Deficiency:** G6PDê°€ ë¶€ì¡±í•˜ë©´ Shieldê°€ êº¼ì§‘ë‹ˆë‹¤(Offline). Oxidative Stressê°€ ì˜¤ë©´ Hemoglobinì´ ì‚°í™”ë˜ì–´ ë³€ì„±ë©ë‹ˆë‹¤.\n    - **Heinz Bodies:** ë³€ì„±ëœ Hemoglobinì´ ë­‰ì¹œ ê²ƒ (Precipitation).\n    - **Bite Cells (Degmacytes):** Spleenì˜ Macrophageê°€ Heinz Bodyë¥¼ 'í•œ ì… ë² ì–´ ë¬¸(Bite)' ìêµ­.\n- ì‚°í™” ìŠ¤íŠ¸ë ˆìŠ¤ë¥¼ ë²„í‹°ì§€ ëª»í•˜ê³  RBCë“¤ì´ INTRAVASCULAR HEMOLYSIS â†’ dark urine.\n### **âš ï¸ Clinical Pearls & Triggers**\n- **Inheritance:** **X-linked Recessive** (ì£¼ë¡œ **Male** í™˜ì).\n- **Triggers (The \"Offending\" Agents):**\n    - **Infection** (Most common trigger! â˜…) - ìš°ë¦¬ ëª¸ì˜ WBCê°€ ë¿œì–´ë‚´ëŠ” Free radical ë•Œë¬¸.\n    - **Antibiotics:** TMP-SMX (Bactrim), Nitrofurantoin.\n    - Dapsone\n    - **Antimalarials:** Primaquine.\n    - **Foods:** Fava beans (Favism).\n- **Symptoms:** **Jaundice**, **Dark Urine** (Cola-colored), **Fatigue**.\n### **ğŸš« The USMLE Trap: Diagnosis Timing**\n- **Scenario:** í™˜ìê°€ **Acute Hemolysis** ìƒíƒœë¡œ ì™”ìŠµë‹ˆë‹¤. Dark urine, Bite cells í™•ì¸ë¨.\n    - Dipstickìƒ hematuria +, but NO blood under microscope. (í•¨ì •)\n        - Why? dipstick detects heme molecule. (molecular testing)\n    - Prussian blueëŠ” ì–‘ì„±: hemosiderin(iron storage complex) positive. = ë©°ì¹ ì´ìƒ ë˜ì—ˆë‹¤ëŠ” ì†Œê²¬\n        - hemolysisë¡œ ì¸í•œ hemoglobinì´ ì˜¤ì¤Œê´€ìœ¼ë¡œ ê°€ë©´ì„œ ì‹ ì¥ì„¸í¬ë“¤ì´ hemoglobin ì¬í™œìš©í•˜ë ¤ê³  í¡ìˆ˜í•¨. ì„¸í¬ë¡œ í¡ìˆ˜í•˜ê³  hbë¥¼ ironìœ¼ë¡œ ì¬í™œìš©í•˜ê¸° ìœ„í•´ hemosiderin (ironì„ ì €ì¥í•˜ëŠ” ë‹¨ìœ„)ìœ¼ë¡œ ë°”ê¿ˆ. ê·¼ë° í•´ë„í•´ë„ hbì´ ë„ˆë¬´ ë§ë‹¤ë³´ë‹ˆê¹Œ ì‹ ì¥ ì„¸í¬ë“¤ì´ í„°ì§. í„°ì§€ë©´ì„œ ìê¸°ë“¤ì´ ì¬í™œìš©í•˜ë ¤ê³  í–ˆë˜ hemosiderinì´ ì˜¤ì¤Œìœ¼ë¡œ í˜ëŸ¬ë‚˜ì˜´.\n- **Question:** What is the best next step?\n- **DON'T DO THIS:** ì§€ê¸ˆ ë‹¹ì¥ **G6PD Enzyme Assay**ë¥¼ ì²˜ë°©í•˜ë©´ ì•ˆ ë©ë‹ˆë‹¤! ğŸ™…â€â™‚ï¸\n    - **Reason (False Negative):** íš¨ì†Œê°€ ë¶€ì¡±í•œ 'ëŠ™ì€ RBC'ë“¤ì€ ì´ë¯¸ ë‹¤ í„°ì ¸ ì£½ì—ˆìŠµë‹ˆë‹¤. ì‚´ì•„ë‚¨ì€ ê±´ íš¨ì†Œ í™œì„±ì´ ë†’ì€ 'ì Šì€ RBC(Reticulocytes)' ë¿ì…ë‹ˆë‹¤. ê²€ì‚¬í•˜ë©´ ìˆ˜ì¹˜ê°€ **ì •ìƒ(Normal)**ìœ¼ë¡œ ë‚˜ì˜µë‹ˆë‹¤. *â€œMeasuring the survivorsâ€*\n- **Correct Step:** Acute episodeê°€ ëë‚˜ê³  **3ê°œì›” ë’¤(3 months later)**ì— ê²€ì‚¬í•©ë‹ˆë‹¤.\n---\n## **2. Paroxysmal Nocturnal Hemoglobinuria (PNH) (1.3.1)**","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-65","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","pathophysiology","mnemonic"]}
{"chunk_type":"transcript_chunk","text":"### **âš“ï¸ Concept: The Missing Anchor**\n- **Definition:** **Acquired Mutation** in the **PIG-A gene** of a hematopoietic stem cell. (ìœ ì „ë˜ëŠ” ê²Œ ì•„ë‹ˆë¼ ì‚´ë‹¤ê°€ ìƒê¸°ëŠ” ê²ƒ!)\n- **Mechanism:**\n    - RBC í‘œë©´ì—ëŠ” **Complement System** (ìš°ë¦¬ ëª¸ì˜ ë©´ì—­ ë¯¸ì‚¬ì¼)ìœ¼ë¡œ ë¶€í„° ìì‹ ì„ ë³´í˜¸í•˜ëŠ” ë°©íŒ¨(**CD55, CD59**)ê°€ ìˆìŠµë‹ˆë‹¤.\n    - ì´ ë°©íŒ¨ë¥¼ RBCì— ë¶™ë“¤ì–´ ë§¤ëŠ” ë°§ì¤„ì´ **GPI Anchor**ì…ë‹ˆë‹¤.\n    - **PIG-A mutation** = GPI Anchorë¥¼ ëª» ë§Œë“¦ = ë°©íŒ¨(CD55/59)ê°€ ë–¨ì–´ì ¸ ë‚˜ê° = **Complement Attack!** ğŸ’£\n### **ğŸŒ™ The \"Nocturnal\" Myth vs. Reality**\n- **Myth:** ë°¤ì—ë§Œ í„°ì§„ë‹¤?\n- **Fact:** **Low-level hemolysis**ëŠ” í•­ìƒ ì¼ì–´ë‚©ë‹ˆë‹¤. í•˜ì§€ë§Œ ë°¤ì— **Hypoventilation** (ìˆ¨ì„ ì–•ê²Œ ì‰¼) â†’ **CO2 Retention** â†’ **Respiratory Acidosis** (pH ê°ì†Œ) â†’ **Complement System í™œì„±í™”** â†’ **Hemolysis ì•…í™”**. ê·¸ë˜ì„œ ì•„ì¹¨ ì²« ì†Œë³€ì´ ì œì¼ ì§„í•©ë‹ˆë‹¤ (**Dark Urine**).\n### **â˜ ï¸ Clinical Triad & Complications**\n1. **Coombs Negative Hemolytic Anemia**\n2. **Pancytopenia** (Stem cell defectë‹ˆê¹Œ WBC, Plateletë„ ì˜í–¥ë°›ìŒ â†’ Aplastic Anemiaì™€ ì‚¬ì´Œ ê´€ê³„).\n3. **Venous Thrombosis (The Killer ğŸ’€):**\n    - **Weird Locations:** **Hepatic vein (Budd-Chiari syndrome)**, Cerebral veins, Mesenteric veins.\n    - Why? Free Hemoglobinì´ **NO (Nitric Oxide)**ë¥¼ ìŠ¤í€ì§€ì²˜ëŸ¼ ë¹¨ì•„ë“¤ì„ â†’ Vasoconstriction + Platelet Aggregation ì´‰ì§„.\n### **ğŸ” Diagnosis & Treatment**\n- **Gold Standard:** **Flow Cytometry** (CD55, CD59 ë¶€ì¬ í™•ì¸).\n    - *Old Test (Do not pick):* Ham test, Sucrose lysis test.\n- **Treatment:**\n    - Supportive care (Iron, Folate).\n    - **Eculizumab:** Terminal Complement Inhibitor (C5 ì–µì œ).\n    - **Safety Warning:** Eculizumab ì‚¬ìš© ì „ ë°˜ë“œì‹œ **Meningococcal Vaccine** (Neisseria meningitidis) ì ‘ì¢… í•„ìˆ˜! (Complement ë§‰ìœ¼ë©´ ìº¡ìŠ ì„¸ê· ì— ì·¨ì•½í•´ì§).\n---\n## **3. Sickle Cell Disease (1.3.2)**\n### **ğŸŒ™ Concept: The Shape-Shifter**\n- **Genetics:** Point mutation (Glu â†’ Val) on Beta-chain. HbS polymerizes when deoxygenated.\n- **Trigger:** Deoxygenation, Dehydration, Acidosis. â†’ RBCê°€ ë‚« ëª¨ì–‘(Sickle)ìœ¼ë¡œ ë³€í•¨ â†’ **Vaso-occlusion** (í˜ˆê´€ ë§‰í˜).\n### **ğŸ”¥ Types of Crisis (USMLE Favorites)**\n| **Crisis Type** | **Feature** | **Key Pearl** |\n| --- | --- | --- |\n| **Vaso-occlusive (Pain)** | Most common. Bone pain (Dactylitis in babies). | Hydration + Pain control (Opioids). |\n| **Acute Chest Syndrome** | **New infiltrate on CXR** + Fever/Resp sx. | Leading cause of death in adults.\nTriggered by fat emboli (from bone necrosis) or infection.\nâ†’ pain in the ribs\nâ†’ ì•„íŒŒì„œ ìˆ¨ ëª»ì‰¼\nâ†’ ë¬´ê¸°í, **low oxygen\nâ†’ more sickling\nâ†’ more lung damage**\nâ†’ â€¦ ì•…ìˆœí™˜\nì¹˜ë£Œ: í•­ìƒì œ (azithromycin for atypical pneumoniae), pain control, oxygen\nâ†’ refractory: transfusion, exchange transfusion |\n| **Splenic Sequestration** | Pediatric emergency. Hypotension + Rapidly enlarging spleen. Normal Reticulocytes | Spleenì´ í”¼ë¥¼ ë‹¤ ë¹¨ì•„ë“¤ì—¬ì„œ Shock ì˜´. Volume resuscitation + Transfusion. |\n| **Aplastic Crisis** | Acute drop in Hb + **Low Reticulocytes**. | **Parvovirus B19** infection. (Destroys erythroid precursors). |","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-85","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"transcript_chunk","text":"### **ğŸ¦  Infection & Prevention**\n- **Autosplenectomy:** ë°˜ë³µì ì¸ Infarctionìœ¼ë¡œ ë¹„ì¥ì´ ìª¼ê·¸ë¼ë“¤ì–´ ê¸°ëŠ¥ ìƒì‹¤ (Functional Asplenia by age 5).\n    - **Risk:** Encapsulated bacteria (**Streptococcus pneumoniae**, **H. influenzae**, **N. meningitidis**)ì— ë§¤ìš° ì·¨ì•½.\n    - **Management:**\n        - **Penicillin Prophylaxis:** Age 5ê¹Œì§€ ë§¤ì¼ ë³µìš©.\n        - **Vaccination:** Pneumococcal, Meningococcal, Hib.\n        - **Hydroxyurea:** Increases **HbF** (Fetal Hemoglobin) â†’ HbS polymerization ë°©í•´.\n- **Osteomyelitis:** Sickle Cell í™˜ìì˜ ê³¨ìˆ˜ì—¼ ì›ì¸ 1ìœ„ëŠ” **Salmonella** (íŠ¹ì´í•˜ê²Œë„ Staph aureusë³´ë‹¤ í”í•¨!).\n- AVN: chornic hip pain with walking. No warmth, No fever. Dead bone ì°Œêº¼ê¸°ê°€ ë¬¼ë¦¬ì ìœ¼ë¡œ ë°©í•´í•¨.\n- Kidney: Renal medulla is hypoxic. Constant sickling â†’ í˜ˆê´€ ë§‰ìŒ. *SCD ë§ê³  Traitì—ì„œë„ ê°€ëŠ¥í•¨.*\n    - Renal papillary necrosis: episodes of painless hematuria\n    - Iso/hypo - sthen - uria: STHEN=to concentrate. ì˜¤ì¤Œ ëŠ¥ì¶• ëŠ¥ë ¥(=ë¬¼ì„ ì¬í¡ìˆ˜í•˜ëŠ” ëŠ¥ë ¥)ì˜ ìƒì‹¤. ìš”ë¶•ì¦ê³¼ ë¹„ìŠ·.\n- Stroke\n    - Ischemic stroke: ì•„ì´ì—ê²Œì„œ ë§ìŒ. ì¢ƒê°™ì€ RBC ë“¤ë•Œë¬¸ì— í˜ˆê´€ë“¤ ìƒì²˜ì…ê³  hyperplasia â†’ ê²½ë™ë§¥ê³¼ ê°™ì€ í° í˜ˆê´€ë“¤ì´ ì¢ì•„ì§.\n    - Hemorrhagic: ì–´ë¥¸ì—ì„œ ë§ìŒ. ë§Œì„±ì ìœ¼ë¡œ ê³µê²©ë°›ì€ í˜ˆê´€ì´ ì•½í•´ì§. â†’ í„°ì§.\n    - Prevention\n        - ì–´ë¦°ì´ì—ê²Œì„œ Transcranial doppler screening: í”¼ê°€íë¥´ëŠ” ì†ë„ë¥¼ ë³¸ë‹¤. ì†ë„ê°€ ë¹ ë¥´ë‹¤ëŠ”ê±´ í˜ˆê´€ì´ ì¢ë‹¤ëŠ”ê²ƒ\n            - í˜ˆê´€ì†ë„ê°€ ë¹ ë¥´ê²Œ ì¸¡ì •ë˜ë©´ HbSë¥¼ í¬ì„?ì‹œí‚¤ê¸°ìœ„í•´ transfusion, exchange transfusion\n- Pregnancy: íƒœë°˜í˜ˆê´€ë„ ì¢ƒë¨\n    - abortion, abruptio placenta, ì „ìê°„ì¦, ì–‘ìˆ˜ê³¼ì†Œì¦, FGR\n    - aspirin\n### Management for Maintenance\n- Vaccination\n- Penicillin until age of 5\n- Folic acid supplementation: bone marrow is working over time. B9ê°€ ê¸ˆë°© ê³ ê°ˆë¨.\n- Hydroxyurea: HbFë¥¼ ëŠ˜ë¦°ë‹¤. Higher affinity for oxygen and DOES NOT sickle. í˜ˆê´€ì— ê¼½ì‚¬ë¦¬ê»´ì„œ HbSì• ë“¤ì´ ì•ˆë­‰ì¹˜ê²Œí•œë‹¤.\n    - Ix: recurrent vaso-occlusive syndrome. hx of Acute chest syndrome.\n---\n## **4. Hereditary Spherocytosis (1.3.3)**\n### **ğŸˆ Concept: The Rigid Sphere**\n- **Pathophysiology:** RBC ë§‰ì„ ì§€ì§€í•˜ëŠ” ë‹¨ë°±ì§ˆ (**Spectrin, Ankyrin**) ìœ ì „ì ê²°í•¨.\n- **Result:** RBCê°€ í‘œë©´ì (Membrane)ì„ ìƒê³  ë™ê·¸ë€ ê³µ ëª¨ì–‘(**Spherocyte**)ì´ ë¨ â†’ ìœ ì—°ì„±ì´ ì—†ì–´ Spleen í†µê³¼ ëª»í•¨ â†’ **Extravascular Hemolysis**.\n- Spleomegaly, Jaundice\n- Pigmented gallstones â˜… BLACK gallstones = ì§€ì†ëœ ìš©í˜ˆë¡œ ì¸í•´ BILIRUBIN gallstonesê°€ ì˜ìƒê¹€ at very young age\n    - ì–´ë¦°ì•„ì´ê°€ ë¹ˆí˜ˆì´ ìˆìœ¼ë©´ì„œ ë‹´ë‚­ì—¼ ì¦ìƒê°™ì´ ìˆìœ¼ë©´ HSì˜ì‹¬í•´ì•¼ë¨! â˜…\n### **ğŸ“Š Diagnosis**\n- **Labs:**\n    - Coombs test -ve â˜… êµ¬í˜• ì í˜ˆêµ¬ë¥¼ ë³´ì´ëŠ” ë‹¤ë¥¸ ë©´ì—­ mediated anemiaë‘ ê°ë³„í•˜ê¸° ìœ„í•´ í•„ìš”í•¨!\n    - **High MCHC** (Mean Corpuscular Hemoglobin Concentration) â˜… Specific finding! (ì„¸í¬ëŠ” ì‘ì•„ì§€ëŠ”ë° Hb ì–‘ì€ ê·¸ëŒ€ë¡œë¼ ë†ë„ ì¦ê°€).\n    - High RDW.\n- **Tests:**\n    - **Osmotic Fragility Test:** (Classic) ì†Œê¸ˆë¬¼ì— ë„£ìœ¼ë©´ ì˜ í„°ì§.\n    - **Eosin-5-Maleimide (EMA) Binding / Flow Cytometry:** (Current Gold Standard).\n### **âœ‚ï¸ Treatment**\n- Folic acid\n- **Splenectomy:** ë¹„ì¥ ì ˆì œê°€ ì¹˜ë£Œë²• (ìš©í˜ˆ ì¥ì†Œë¥¼ ì—†ì• ë²„ë¦¼).\n    - **Outcome:** SpherocytesëŠ” ê·¸ëŒ€ë¡œ ìˆì§€ë§Œ, ë¹ˆí˜ˆì€ í•´ê²°ë¨.\n        - *5ì‚´ ì´í›„ë¡œ splenectomyë¥¼ ë¯¸ë£¨ë©´ ì¢‹ìŒ*. ë©´ì—­ì²´ê³„ê°€ ì•ˆì¢‹ì€ 5ì‚´ ì „ì—ëŠ” Strep. pneumoniae ê°™ì€ encapuslated ê· ë“¤ë¡œë¶€í„° ìµœëŒ€í•œ ë³´í˜¸í•˜ê¸° ìœ„í•¨ì„.\n        - **Howell-Jolly Bodies:** ë¹„ì¥ ì ˆì œ í›„ ë§ì´ˆ í˜ˆì•¡ ë„ë§ì—ì„œ ë³´ì„ (ë³´ë¼ìƒ‰ í•µ ì¡°ê°ì´ ì œê±° ì•ˆ ë˜ê³  ë‚¨ì•„ìˆëŠ” ê²ƒ).\n---","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-105","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","diagnosis","treatment","pathophysiology","tree"]}
{"chunk_type":"recap_summary","text":"## **âš¡ï¸ Rapid Fire Recap (High Yield Q&A)**\nì˜¤ë””ì˜¤ ë§ˆì§€ë§‰ì— ë‚˜ì˜¨ Rapid Fire Recapì…ë‹ˆë‹¤. ì‹œí—˜ ì§ì „ ë¦¬ë§ˆì¸ë“œìš©!\n- **Q: African American male, back pain, dark urine after taking TMP-SMX?**\n    - **A:** **G6PD Deficiency**. (Antibiotic trigger).\n- Q: G6PD ë¹ˆí˜ˆí™˜ìì—ì„œ í”¼í•´ì•¼í•  UTIì•½\n    - A: TMPSMX(Bactrim), Nitrofurantoin\n- **Q: Best test for G6PD during active hemolysis?**\n    - **A:** **None.** Wait 3 months. (False negative risk).\n- **Q: Dark urine in the morning, history of DVT(Budd Chiari) in weird places?**\n    - **A:** **PNH (Paroxysmal Nocturnal Hemoglobinuria)**.\n    - **A:** **Flow Cytometry** (Looking for CD55/59 absence).\n- **Q: Sickle Cell patient with fever, chest pain, new infiltrate on CXR?**\n    - **A:** **Acute Chest Syndrome**. (Treat aggressively!).\n    Ceftriaxone, Azithromycin â˜…\n- Q: SCD stroke prevention\n    - A: ë‡Œ ë„í”ŒëŸ¬ í˜ˆë¥˜ ì†ë„ ê²€ì‚¬.\n- **Q: Sickle Cell patient with osteomyelitis. Most likely bug?**\n    - **A:** **Salmonella**.\n- Q: HSì—ì„œ í˜ˆì—­í•™ì  ì†Œê²¬\n    - High MCHC (due to dehydration)\n- **Q: High MCHC, splenomegaly, Coombs negative?**\n    - **A:** **Hereditary Spherocytosis**.\n- **Q: Treatment for Hereditary Spherocytosis?**\n    - **A:** **Splenectomy** (Don't forget vaccines first!).\n---\n\"All right, everyone, settle in. We are back, and today, we are going directly into the trenches. We are. I'm your attending for this session, and my job is pretty simple. I'm here to make sure that when you see a patient, or, you know, a question stem on your board exam, you know exactly what the next best step is. No memorizing. We are not just memorizing facts here; we're building that clinical intuition.\"\n---\n## ğŸ“‹ Overview: Sickle Cell Disease (SCD)","subject":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","page_title":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","episode":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","section_path":["LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f"],"source_doc_id":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","source_page":null,"source_anchor":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f-120","focus_area":"LM_Blood 1 2fc46f2986ee801eb24dff366f2f482f","tags":["usmle-step2","core","recap","treatment","tree"]}
